Top Markets
Coin of the day
Cypherpunk Technologies Inc. Cypherpunk Technologies Inc.

Cypherpunk Technologies Inc.

CYPH
Classifica tra le azioni #19170
Cypherpunk Technologies Inc. is a biopharmaceutical company dedicated to the... Cypherpunk Technologies Inc. is a biopharmaceutical company dedicated to the acquisition and development of antibody treatments for cancer. The firm's flagship investigational drug, DKN-01, is a monoclonal antibody designed to suppress Dickkopf-related protein 1 and is currently progressing through multiple clinical trials for various esophagogastric, gynecologic, and colorectal cancers. Additionally, the company is advancing FL-501, another monoclonal antibody that targets the GDF-15 protein, which is presently in preclinical development. Cypherpunk has established an agreement with Adimab, LLC and BeiGene, Ltd., granting it options and licenses to advance and market DKN-01 across Asia (excluding Japan), Australia, and New Zealand. Founded in 2011, the company operates from Cambridge, Massachusetts, and was formerly known as Leap Therapeutics, Inc. until its renaming in November 2025.
Prezzo delle azioni
$1.62
Ultima sincronizzazione: 2026-08-25
Capitalizzazione di mercato
$172.47M
Variazione (1 giorno)
-3.57%
Variazione (1 anno)
446.74%
Paese
US
Scambia Cypherpunk Technologies Inc. (CYPH)

Categoria

Storico del prezzo dell'azione per Cypherpunk Technologies Inc. (CYPH)
Prezzo di chiusura più alto: $0.94 il 2026-08-01

Prezzo di chiusura più basso: $75.65 il 2017-01-01
Storico del prezzo dell'azione di Cypherpunk Technologies Inc. dal 2017 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) -31.92%
2025 -58.69%
2024 -5.41%
2023 -33.87%
2022 -82.32%
2021 38.52%
2020 121.83%
2019 -68.29%
2018 -56.56%
2017 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$553.09 42.85%
US
$1.02K 44.02%
NL
$158.64 541.49%
US
$121.62 -12.98%
AU
$769.41 6.94%
CH